EG627821 Inhibitors
Eddm13, a gene predicted to localize in the extracellular region, encodes the epididymal protein 13, suggesting a role in intercellular communication or structural functions. While the precise molecular functions of Eddm13 remain to be fully elucidated, understanding its potential inhibition provides valuable insights into the intricate regulatory networks that govern its extracellular functions. The predicted extracellular localization implies involvement in cellular interactions, potentially influencing cellular signaling cascades, or contributing to the structural integrity of the extracellular matrix. Exploring mechanisms of inhibition for Eddm13 involves considering a variety of chemical agents that target key cellular processes. These processes, ranging from oxidative stress modulation to interference with intracellular signaling pathways, offer potential avenues for hindering Eddm13 function. For instance, inhibitors targeting cellular redox balance, such as N-Acetyl-L-cysteine, could impact Eddm13 by altering the oxidative stress levels, suggesting a link between redox status and the protein's extracellular role.
Similarly, compounds affecting major signaling pathways, such as the PI3K/AKT pathway, could indirectly influence Eddm13 by disrupting processes crucial for its predicted extracellular functions. The intricate interplay between these chemical inhibitors and cellular processes reveals a nuanced understanding of the potential regulatory mechanisms that govern Eddm13's extracellular activities. Furthermore, inhibitors disrupting fundamental cellular processes, including protein synthesis (Cycloheximide) or glycolysis (2-Deoxyglucose), may provide insights into how Eddm13's function is intricately tied to these cellular activities. Autophagy inhibitors, such as Bafilomycin A1 and Chloroquine, shed light on the potential connection between Eddm13 and cellular homeostasis, implicating the involvement of autophagy in regulating its extracellular dynamics. Inhibitors targeting specific kinases, such as p38 MAPK (SB203580) and MEK (U0126), offer glimpses into the potential impact of signaling cascades on Eddm13's extracellular functions. Altogether, the diverse mechanisms of inhibition elucidate the complex regulatory landscape of Eddm13 and provide a foundation for further investigations into the intricacies of its extracellular roles.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
N-Acetyl-L-cysteine, an antioxidant and precursor to glutathione, influences cellular redox balance. By modulating reactive oxygen species levels, it indirectly impacts Eddm13 inhibition, as oxidative stress is implicated in altering the function of extracellular proteins. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3-kinase inhibitor, directly affects the PI3K/AKT pathway. This impacts Eddm13 as the PI3K/AKT pathway is known to regulate extracellular protein functions, influencing its localization and potentially hindering Eddm13's predicted extracellular role. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxy-D-glucose inhibits glycolysis, impacting cellular metabolism. Given that extracellular proteins' secretion is energy-dependent, inhibiting glycolysis may indirectly hinder Eddm13's extracellular localization and function. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis. This direct inhibition may affect Eddm13 by reducing the overall availability of newly synthesized proteins, potentially impacting its extracellular localization and function. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine, an Akt inhibitor, directly affects the PI3K/AKT pathway. This interference may indirectly inhibit Eddm13, as the PI3K/AKT pathway regulates processes that impact extracellular protein functions, potentially altering the predicted extracellular role of Eddm13. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 inhibits autophagy, impacting cellular homeostasis. As autophagy is linked to extracellular protein regulation, inhibiting it may indirectly affect Eddm13's predicted extracellular function, potentially altering its localization or secretion. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, directly influences the p38 MAPK pathway. This pathway can modulate extracellular protein functions, and inhibiting it may indirectly hinder Eddm13, altering its localization or function in the extracellular region. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis, impacting cellular processes. As calcium signaling is involved in extracellular protein regulation, inhibiting it may indirectly affect Eddm13's predicted extracellular function, potentially altering its localization or secretion. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3-kinase inhibitor, directly affects the PI3K/AKT pathway. This interference may indirectly inhibit Eddm13, as the PI3K/AKT pathway regulates processes that impact extracellular protein functions, potentially altering the predicted extracellular role of Eddm13. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine, an autophagy inhibitor, impacts cellular homeostasis. As autophagy is linked to extracellular protein regulation, inhibiting it may indirectly affect Eddm13's predicted extracellular function, potentially altering its localization or secretion. | ||||||